Index RUT
P/E 102.33
EPS (ttm) 0.93
Insider Own 1.62%
Shs Outstand 15.08M
Perf Week -4.25%
Market Cap 1.44B
Forward P/E 32.81
EPS next Y 2.92
Insider Trans -3.60%
Shs Float 14.85M
Perf Month 1.11%
Income 14.10M
PEG 11.37
EPS next Q 0.69
Inst Own 102.76%
Short Float 4.07%
Perf Quarter 15.45%
Sales 645.70M
P/S 2.24
EPS this Y 3.31%
Inst Trans 12.72%
Short Ratio 5.42
Perf Half Y 0.61%
Book/sh 32.02
P/B 2.99
EPS next Y 10.23%
ROA 1.38%
Short Interest 0.60M
Perf Year 5.34%
Cash/sh 7.75
P/C 12.35
EPS next 5Y 9.00%
ROE 2.89%
52W Range 76.18 - 113.63
Perf YTD 2.71%
Dividend Est. -
P/FCF 19.40
EPS past 5Y -0.50%
ROI 2.04%
52W High -15.81%
Beta 1.47
Dividend TTM 1.76 (1.84%)
Quick Ratio 1.78
Sales past 5Y 6.41%
Gross Margin 17.26%
52W Low 25.57%
ATR (14) 2.58
Dividend Ex-Date Nov 15, 2024
Current Ratio 1.78
EPS Y/Y TTM -45.37%
Oper. Margin 10.11%
RSI (14) 55.03
Volatility 2.21% 2.70%
Employees 6720
Debt/Eq 0.53
Sales Y/Y TTM 9.22%
Profit Margin 2.18%
Recom 1.67
Target Price 108.00
Option/Short Yes / Yes
LT Debt/Eq 0.43
EPS Q/Q -23.85%
Payout 134.52%
Rel Volume 1.00
Prev Close 96.29
Sales Surprise 2.26%
EPS Surprise 0.88%
Sales Q/Q 12.02%
Earnings Nov 05 AMC
Avg Volume 111.62K
Price 95.66
SMA20 -0.06%
SMA50 8.07%
SMA200 1.13%
Trades
Volume 110,956
Change -0.65%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-07-24 Downgrade
BofA Securities
Buy → Neutral
$114 → $90
Sep-22-23 Initiated
JP Morgan
Overweight
$108
Jun-30-23 Initiated
BofA Securities
Buy
$138
Dec-14-21 Upgrade
CJS Securities
Market Perform → Market Outperform
$120
Aug-06-21 Reiterated
Barrington Research
Outperform
$130 → $139
May-07-21 Upgrade
Barrington Research
Mkt Perform → Outperform
$130
May-03-21 Upgrade
Jefferies
Hold → Buy
$130 → $135
Feb-26-21 Downgrade
Barrington Research
Outperform → Mkt Perform
Jun-08-20 Reiterated
Barrington Research
Outperform
$84 → $95
Apr-30-20 Downgrade
Sidoti
Buy → Neutral
Mar-11-20 Upgrade
Sidoti
Neutral → Buy
$128
Feb-28-20 Reiterated
Barrington Research
Outperform
$130 → $120
Nov-08-19 Upgrade
Barrington Research
Mkt Perform → Outperform
Mar-08-19 Initiated
William Blair
Outperform
Nov-03-17 Downgrade
Barrington Research
Outperform → Mkt Perform
Sep-08-17 Upgrade
Sidoti
Neutral → Buy
Jul-03-17 Upgrade
Barrington Research
Mkt Perform → Outperform
$68
Mar-17-17 Downgrade
Barrington Research
Outperform → Mkt Perform
Nov-04-16 Upgrade
Barrington Research
Mkt Perform → Outperform
$61
Aug-05-16 Downgrade
Barrington Research
Outperform → Mkt Perform
Show Previous Ratings
Dec-02-24 07:30AM
Nov-12-24 04:05PM
Nov-08-24 02:35AM
Nov-05-24 06:30PM
05:28PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
07:50AM
Nov-04-24 10:47AM
Oct-31-24 04:05PM
Oct-29-24 10:01AM
Oct-23-24 02:30PM
09:10AM
Oct-09-24 06:25PM
Oct-08-24 05:38PM
07:58AM
04:05PM
Loading…
Oct-07-24 04:05PM
Sep-04-24 01:16AM
Sep-03-24 07:30AM
Aug-21-24 04:05PM
Aug-13-24 05:50PM
04:47PM
(Associated Press Finance)
04:30PM
Aug-01-24 12:31PM
Jul-26-24 07:30AM
Jul-03-24 02:20PM
Jun-05-24 04:05PM
Jun-01-24 02:42AM
May-30-24 04:05PM
02:42AM
May-17-24 02:36AM
04:05PM
Loading…
May-09-24 04:05PM
11:26AM
04:09AM
(Thomson Reuters StreetEvents)
03:27AM
May-07-24 10:55PM
07:00PM
06:02PM
(Associated Press Finance)
05:00PM
May-01-24 11:09AM
08:30AM
Apr-23-24 04:05PM
Apr-01-24 07:30AM
Mar-11-24 07:00AM
Mar-08-24 05:15PM
Mar-05-24 10:10AM
Mar-01-24 04:41AM
(Thomson Reuters StreetEvents)
Feb-28-24 06:05PM
05:31PM
05:14PM
(Associated Press Finance)
04:45PM
Feb-21-24 10:00AM
Feb-18-24 06:09AM
Feb-05-24 04:30PM
Jan-09-24 08:25AM
Dec-16-23 07:01AM
Dec-06-23 10:57PM
Dec-01-23 08:59AM
Nov-09-23 04:05PM
02:57PM
05:52AM
(Thomson Reuters StreetEvents)
Nov-07-23 06:28PM
(Associated Press Finance)
04:30PM
Nov-01-23 08:30AM
Oct-30-23 05:50PM
Oct-19-23 11:40AM
Oct-15-23 10:30AM
Oct-13-23 04:05PM
Oct-03-23 11:40AM
Oct-02-23 08:30AM
Aug-16-23 04:05PM
Aug-12-23 08:07AM
Aug-10-23 02:01AM
01:37AM
(Thomson Reuters StreetEvents)
Aug-08-23 06:40PM
05:40PM
05:05PM
Aug-02-23 11:08AM
Aug-01-23 09:00AM
Jul-31-23 02:13PM
Jul-20-23 04:05PM
Jul-19-23 11:40AM
Jul-07-23 08:49AM
Jun-21-23 08:00PM
Jun-20-23 08:00AM
Jun-19-23 08:38AM
Jun-18-23 09:25AM
Jun-05-23 11:40AM
May-31-23 04:02PM
May-30-23 04:01PM
May-26-23 06:58AM
May-25-23 08:27AM
May-24-23 09:59PM
May-23-23 04:30PM
May-18-23 11:40AM
May-16-23 04:05PM
May-12-23 06:09AM
May-04-23 04:01PM
May-03-23 05:55PM
04:01PM
May-01-23 11:40AM
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The company was founded in 1990 and is headquartered in Houston, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HENDRICKSON CAREY P Chief Financial Officer Dec 09 '24 Sale 96.25 516 49,665 20,469 Dec 09 06:30 PM HENDRICKSON CAREY P Affiliate Dec 06 '24 Proposed Sale 96.41 516 49,747 Dec 06 02:01 PM Richard S. Binstein Officer Nov 22 '24 Proposed Sale 98.00 1,200 117,600 Nov 22 03:40 PM Harris Bernard A Jr Director Nov 12 '24 Sale 92.95 2,000 185,900 16,726 Nov 13 06:00 PM HAM NANCY Director Nov 08 '24 Sale 96.72 1,172 113,356 1,112 Nov 12 06:00 PM REEVE GRAHAM D. COO Nov 08 '24 Sale 96.29 1,724 166,004 7,106 Nov 12 06:00 PM Williams Eric Joseph Co-Chief Operations Officer Nov 08 '24 Sale 95.84 2,000 191,680 14,814 Nov 12 06:00 PM Trier Clayton Director Nov 08 '24 Sale 95.78 2,000 191,560 6,424 Nov 12 06:00 PM BERNARD HARRIS JR. Director Nov 12 '24 Proposed Sale 92.95 2,000 185,897 Nov 12 04:19 PM CLAYTON K TRIER &VIRGINIA TRIE Director Nov 08 '24 Proposed Sale 95.78 2,000 191,564 Nov 08 04:36 PM ERIC WILLIAMS Officer Nov 08 '24 Proposed Sale 95.83 2,000 191,660 Nov 08 04:27 PM Graham Reeve COO Nov 08 '24 Proposed Sale 96.29 1,724 166,001 Nov 08 03:19 PM HAM NANCY Director Nov 08 '24 Proposed Sale 95.59 1,172 112,037 Nov 08 11:55 AM Gilmartin Kathleen A Director Sep 03 '24 Buy 86.09 2,000 172,180 18,904 Sep 03 06:38 PM REEVE GRAHAM D. COO Aug 21 '24 Sale 82.50 1,724 142,230 7,038 Aug 21 05:49 PM Graham Reeve COO Aug 20 '24 Proposed Sale 84.01 1,724 144,833 Aug 20 05:01 PM READING CHRISTOPHER J Chairman of the Board and CEO May 30 '24 Sale 100.26 2,900 290,754 95,838 May 31 06:00 PM READING CHRISTOPHER J Chairman of the Board and CEO May 28 '24 Sale 102.13 1,100 112,343 99,738 May 29 05:27 PM READING CHRISTOPHER J Chairman of the Board and CEO May 29 '24 Sale 100.13 1,000 100,130 98,738 May 29 05:27 PM KUNTZ EDWARD L Director May 15 '24 Sale 107.57 2,500 268,925 3,280 May 16 05:14 PM Williams Eric Joseph Co-Chief Operations Officer May 10 '24 Sale 104.22 2,500 260,550 16,814 May 14 06:19 PM REEVE GRAHAM D. COO May 10 '24 Sale 105.46 1,724 181,813 6,970 May 14 06:15 PM HENDRICKSON CAREY P Chief Financial Officer Mar 13 '24 Sale 107.28 1,800 193,103 21,186 Mar 14 05:23 PM Binstein Richard EVP Gen'l Counsel & Secretary Mar 13 '24 Sale 106.55 2,000 213,100 15,006 Mar 14 05:11 PM Trier Clayton Director Mar 13 '24 Sale 107.00 400 42,800 7,000 Mar 14 05:05 PM HAM NANCY Director Mar 13 '24 Sale 107.89 500 53,945 860 Mar 14 04:21 PM REEVE GRAHAM D. COO Mar 04 '24 Sale 104.39 2,629 274,441 6,902 Mar 05 06:28 PM Williams Eric Joseph Co-Chief Operations Officer Mar 04 '24 Sale 104.96 1,500 157,440 19,314 Mar 05 06:15 PM KUNTZ EDWARD L Director Mar 04 '24 Sale 104.26 2,500 260,650 5,780 Mar 05 06:10 PM Trier Clayton Director Dec 13 '23 Sale 92.26 1,170 107,944 7,400 Dec 14 05:09 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite